Abstract:Pathogenesis of rheumatic heart disease (RHD) has been investigated but the precise mechanism remains unclear, in addition to group A streptococcal infection, both genetic and environmental factors, as well as humoral and cellular autoimmune responses are involved in the development of RHD [ [1] Guilherme L. Kalil J. Rheumatic fever and rheumatic heart disease: cellular mechanisms leading autoimmune reactivity and disease. J. Clin. Immunol. 2010; 30: 17-23 Crossref PubMed Scopus (118) Google Scholar ]. The recent study by Soares et al. reported the levels of imflammatory cytokines of CD4+ T cell subsets were associated with RHD severity [ [2] Soares A.C.D. Passos L.S.A. Sable C. Beaton A. Ribeiro V.T. Gollob K.J. et al. Circulating cytokines predict severity of rheumatic heart disease. Int. J. Cardiol. 2019; 289: 107-109 Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar ], which could provide more evidence for the clinical risk stratification and development of individualized solution. However, the specific RHD valve lesion was not reported in this study, the severity of RHD was defined as the need for surgical intervention, but the proportion of mitral stenosis, mitral regurgitation and mixed valve lesion was not mentioned [ [2] Soares A.C.D. Passos L.S.A. Sable C. Beaton A. Ribeiro V.T. Gollob K.J. et al. Circulating cytokines predict severity of rheumatic heart disease. Int. J. Cardiol. 2019; 289: 107-109 Abstract Full Text Full Text PDF PubMed Scopus (11) Google Scholar ]. In fact, RHD has certain heterogeneities considering its age of onset, mode of presentation, and specific valvular abnormality [ [3] Remenyi B. ElGuindy A. Smith Jr., S.C. Yacoub M. Holmes Jr., D.R. Valvular aspects of rheumatic heart disease. Lancet. 2016; 387: 1335-1346 Abstract Full Text Full Text PDF PubMed Scopus (50) Google Scholar ]. Patients with pure mitral regurgitation were younger, and had higher possibility of ongoing rheumatic activity than patients with pure mitral stenosis or mixed mitral lesion [ [4] Marcus R.H. Sareli P. Pocock W.A. Barlow J.B. The spectrum of severe rheumatic mitral valve disease in a developing country: correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann. Intern. Med. 1994; 120: 177-183 Crossref PubMed Scopus (151) Google Scholar , [5] Zühlke L. Engel M.E. Karthikeyan G. Rangarajan S. Mackie P. Cupido B. et al. Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the Global Rheumatic Heart Disease Registry (the REMEDY study). Eur. Heart J. 2014; 36: 1115-1122 Crossref PubMed Scopus (258) Google Scholar ]. As the prevalence of mitral stenosis increases with age, the stenosing valve lesions are speculated as the degenerative sequelae of previous rheumatic inflammation and represent the “burned out” end stage of the disease, which was morphologically confirmed by histologic assessment of the mitral valve [ [4] Marcus R.H. Sareli P. Pocock W.A. Barlow J.B. The spectrum of severe rheumatic mitral valve disease in a developing country: correlations among clinical presentation, surgical pathologic findings, and hemodynamic sequelae. Ann. Intern. Med. 1994; 120: 177-183 Crossref PubMed Scopus (151) Google Scholar ]. But there is scarce data regarding the homogeneity and heterogeneity of autoimmune cell response and inflammatory cytokines in different patterns of rheumatic valve involvement. Recent years in developing countries the majority cases of RHD are mitral stenosis, but pure mitral regurgitation could not be neglected in the research of pathogenesis of RHD.

A Study on the Changes of Collagen Content in Mitral Valve and Aortic Valve of Rheumatic Heart Disease

Assessment of Left Atrial Strain in Patients Pre-and Post-Mitral Valvuloplasty by Using Two-Dimensional Speckle Tracking Echocardiography

Expression of Fibrillin-1 and Type Ⅰ Collagen on Aortic Valve in Children with Rheumatic Heart Diseases

Clinical Significance of Markers of Collagen Metabolism in Rheumatic Mitral Valve Disease

Expression of matrix metallproteinases and their tissue inhibitors in mitral valve with rheumatic heart disease

Effect of the change of interstitia collagen and blood serum index on cardiac function in CD patients with different types myocardial fibrosis

New insight into the role of lipid metabolism-related proteins in rheumatic heart valve disease

Biological Characteristics of Valvular Interstitial Cells in Rheumatic Valvular Disease

CD4+ T Cells and TGFβ1/MAPK Signal Pathway Involved in the Valvular Hyperblastosis and Fibrosis in Patients with Rheumatic Heart Disease.

Mechanism of Atrial Fibrillation is Related to Changes of Type Iv Collagen in Rheumatic Heart Valvular Disease

Quantification of load-dependent changes in the collagen fiber architecture for the strut chordae tendineae-leaflet insertion of porcine atrioventricular heart valves

Should the Distribution of Valve Lesion Be Considered in the Autoimmune Response of Rheumatic Heart Disease?

Collagen fiber regulation in human pediatric aortic valve development and disease

Correlation between circulating fibrosis biomarkers with left atrial function and left atrial volume index in rheumatic mitral stenosis

A Hospital-Based Survey of Patients with Severe Valvular Heart Disease in China

Study on myocardial collagen Ⅰ, Ⅲ remodeling in different phases after myocardial infarction

Study of Pathomorph and Ultrastructure for Porcine Valve Decline in Human Body

Study on the Relationship Between Inflammatory Markers of the Patients with Rheumatic Mitral Valve Disease in the Peripheral Blood

Cardiac collagen metabolism in murine viral heart diseases

Changes of Left Ventricular Myocardial Collagen Fibers and Osteopontin Expression in Hypertrophic Cardiomyopathy

Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization